Abiomed Forecasts Recover Micropump U.S. Approval In 2006
This article was originally published in The Gray Sheet
Executive Summary
Abiomed expects profitability in 2007 following U.S. approval of Recover 5.0 and 2.5 second-generation micropumps, which it acquired from Impella CardioSystems AG in April